Original language | English |
---|---|
Pages (from-to) | 1442-1446 |
Number of pages | 5 |
Journal | Haematologica |
Volume | 108 |
Issue number | 5 |
DOIs | |
Publication status | Published - May 2023 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Haematologica, Vol. 108, No. 5, 05.2023, p. 1442-1446.
Research output: Contribution to journal › Letter › Academic › peer-review
TY - JOUR
T1 - Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma
AU - Knörr, Fabian
AU - Schellekens, Kim P.J.
AU - Schoot, Reineke A.
AU - Landman-Parker, Judith
AU - Teltschik, Heiko Manuel
AU - Förster, Jan
AU - Riquelme, Amambay
AU - Huitema, Alwin D.R.
AU - van Eijkelenburg, Natasha K.A.
AU - Beishuizen, Auke
AU - Zwaan, C. Michel
AU - Woessmann, Wilhelm
AU - van der Lugt, Jasper
N1 - Funding Information: KS, RS, AH, NvE, CMZ, AB and JvdL received institutional funding from Pfizer. FK, HT, AR, JF, JLP and WW have no conflicts of interest to declare. Funding Information: Pfizer Inc. provided funding and a clinical research collaboration to implement the CRISP trial. The CRISP trial was sponsored by Erasmus MC Sophia Children’s Hospital, Department of Pediatrics, Rotterdam, The Netherlands, and was funded by the Erasmus MC Vriendenfonds Funding Information: Pfizer Inc. provided funding and a clinical research collaboration to implement the CRISP trial. The CRISP trial was sponsored by Erasmus MC Sophia Children’s Hospital, Department of Pediatrics, Rotterdam, The Netherlands, and was funded by the Erasmus MC Vriendenfonds (now Erasmus MC Foundation), Pfizer and Go4Children to CMZ. The NHL-BFM Registry 2012 was supported by grants from the Deutsche Kinderkrebsstiftung to WW (DKS 2014.11, 2016.24, 2018.21, 2020.15).
PY - 2023/5
Y1 - 2023/5
UR - http://www.scopus.com/inward/record.url?scp=85147832494&partnerID=8YFLogxK
U2 - 10.3324/haematol.2022.281896
DO - 10.3324/haematol.2022.281896
M3 - Letter
C2 - 36519329
AN - SCOPUS:85147832494
SN - 0390-6078
VL - 108
SP - 1442
EP - 1446
JO - Haematologica
JF - Haematologica
IS - 5
ER -